OÜ X7 Clinicals and Pharmaceuticals Research EU
OÜ X7 Clinicals and Pharmaceuticals Research EU is a OÜ based in Tallinn, registry code 14119880, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €23 512 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 23 512 €above 62% of companiesindustry median 14 442 € · companies in the industry: 318
- Revenue · 2025 72 816 €above 90% of companiesindustry median 0 € · companies in the industry: 1 073
- Net profit margin · 2025 -0.3 %above 29% of companiesindustry median 13.5 % · companies in the industry: 597
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 23 512 | 538 | — | — |
| Q2 2026 | 701 | — | — | — |
| Q1 2026 | 33 911 | — | — | — |
| Q4 2025 | 18 326 | — | — | — |
| Q3 2025 | 4 828 | — | — | — |
| Q2 2025 | 12 661 | 594 | — | — |
| Q1 2025 | 29 399 | — | — | — |
| Q4 2024 | 60 771 | — | — | — |
| Q3 2024 | 18 650 | — | — | — |
| Q2 2024 | 37 192 | — | — | — |
| Q1 2024 | 51 285 | — | — | — |
| Q4 2023 | 99 618 | — | — | — |
| Q3 2023 | 40 504 | — | — | — |
| Q2 2023 | 7 838 | — | — | — |
| Q1 2023 | 25 456 | — | — | — |
| Q4 2022 | 68 702 | — | — | — |
| Q3 2022 | — | — | — | — |
| Q2 2022 | 56 133 | — | — | — |
| Q1 2022 | 28 804 | — | — | — |
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|
| 2025 | 72 816 | -254 | 31 576 | 21 039 | 0 |
| 2024 | 102 287 | 9 946 | 157 486 | 23 399 | 0 |
| 2023 | 163 220 | -12 772 | 138 314 | 13 453 | 0 |
| 2022 | 137 344 | -23 099 | 169 442 | 26 225 | 0 |
| 2021 | 107 812 | 45 563 | 66 137 | 51 824 | 0 |
| 2020 | 19 542 | 2 471 | 14 533 | 6 261 | 0 |
| 2019 | 33 577 | -1 834 | 34 937 | 3 790 | 0 |
| 2018 | — | — | — | — | 0 |
| 2017 | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 5 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 2 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 1 Mar 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 26 May 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 15 Apr 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 11 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 12 Oct 2020 | Company’s own | e-Äriregister |
Board
- Tatjana SemõkinaBoard member · since 12 Oct 2020
- Olga LembinenBoard member · since 6 May 2021
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Tatjana SemõkinaNatural person · 2 500 €
Beneficial owners
- Tatjana SemõkinaDirect ownership · since 26 May 2023
Founders and other persons
- Natalia SimenivaFounder · 2 500 € · 22 Sep 2016
Related companies
Activities (EMTAK)
- 72101Research and experimental development on natural sciences and engineering Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50037811 / 8 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50037811 / 7 6 May 2021 |
Amendment entry | In force 6 May 2021 |
||
| Ä 50037811 / 6 12 Oct 2020 |
Amendment entry | In force 12 Oct 2020 |
||
| Ä 50037811 / 5 12 Oct 2020 |
Amendment entry | In force 12 Oct 2020 |
||
| Ä 50037811 / 4 12 Feb 2019 |
Amendment under Commercial Code § 525 (2) | In force 12 Feb 2019 |
||
| Ä 50037811 / 3 19 Jan 2018 |
Amendment entry | In force 19 Jan 2018 |
||
| Ä 50037811 / 2 12 Dec 2017 |
Amendment entry | In force 12 Dec 2017 |
||
| Ä 50037811 26 Sep 2016 |
First entry | In force 26 Sep 2016 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data